New York, N.Y., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Human Continuum Inc. (“HC” or “the Company”), a developer of ...
Dr. Law will lead the Company’s efforts to develop and advance an integrated platform of exosome-based therapies, topical ...
Biopharmaceutical discovery, development and manufacturing requires the use of genetic analysis across the development continuum. Sanger sequencing and fragment analysis by capillary electrophoresis ...